MDSCs are closely involved in tumor progression, metastasis, and therapy resistance via the promotion of Treg proliferation and the secretion of immunosuppressive molecules, including arginase 1 (Arg1), inducible nitric oxide synthase (iNOS), reactive oxygen species (ROS), and prostaglandin E2 (PGE2). The gene discussed is ARG1; the disease is neoplasm.